{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Retail sales for January fell 0.9 percent, the Commerce Department said today, pulled down by a sharp drop in demand for cars as automakers cut back on financial incentives. But sales outside the auto industry posted the biggest rise in more than two years. Excluding motor vehicles and parts, sales increased 1.3 percent, far ahead of forecasts of a 0.5 percent rise.", "headline": {"main": "Auto Sales Off Markedly; Other Retail Sales Rise"}, "abstract": "Commerce Department reports retail sales for January fell 0.9 percent; sales increased 1.3 percent, excluding auto sales; car sales dropped 7.5 percent in January; sales at clothing and accessories stores rose modest 0.3 percent; Labor Department reports initial claims for jobless benefits fell by 18,000, to seasonally adjusted 377,000, in week ended Feb 8; four-week moving average of claims rose 3,500, to 389,000; says import prices increased sharply in January, largely from 12.4 percent rise in oil prices (M)", "print_page": "12", "word_count": "374", "_id": "4fd2266f8eb7c8105d7ae11d", "snippet": "Retail sales for January fell 0.9 percent, the Commerce Department said today, pulled down by a sharp drop in demand for cars as automakers cut back on financial incentives.    But sales outside the auto industry posted the biggest rise in more than...", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/14/business/auto-sales-off-markedly-other-retail-sales-rise.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "LABOR DEPARTMENT"}, {"name": "organizations", "value": "COMMERCE DEPARTMENT"}, {"name": "subject", "value": "SALES"}, {"name": "subject", "value": "AUTOMOBILES"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "UNEMPLOYMENT INSURANCE"}, {"name": "subject", "value": "UNITED STATES ECONOMY"}, {"name": "subject", "value": "OIL (PETROLEUM) AND GASOLINE"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "APPAREL"}, {"name": "subject", "value": "RETAIL STORES AND TRADE"}], "byline": null, "document_type": "article", "pub_date": "2003-02-14T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The chief executive of GlaxoSmithKline, one of two drug makers accused by the New York attorney general of inflating drug costs for government health programs and consumers, said yesterday that it would fight the accusations. The executive, Jean-Pierre Garnier, said: ''We will fight because we've done nothing wrong. The money goes into the pocket of the physician. Why they're suing us is hard to understand.'' Mr. Garnier made the comments on Bloomberg Television after the New York attorney general, Eliot Spitzer, filed suit against Glaxo and Pharmacia, accusing them of trying to gain market share by giving discounts on certain drugs to doctors, who then bill government programs for the full price. A spokesman for Pharmacia, Paul Fitzhenry, said the company was cooperating with the attorney general's office and hoped to avoid litigation. He said the company thought the issue should be determined by federal legislation.", "headline": {"main": "GLAXO SAYS IT WILL FIGHT NEW YORK LAWSUIT", "kicker": "COMPANY NEWS"}, "abstract": "GlaxoSmithKline chief executive Jean-Pierre Garnier says it will fight accusations by New York State Atty Gen Eliot L Spitzer that company inflated drug costs for government health programs and consumers; Pharmacia, which is also named in Spitzer's suit, says company is cooperating with Spitzer's office and hopes to avoid litigation (S)", "print_page": "4", "word_count": 148, "_id": "4fd241c18eb7c8105d7da160", "snippet": "The chief executive of GlaxoSmithKline, one of two drug makers accused by the New York attorney general of inflating drug costs for government health programs and consumers, said yesterday that it would fight the accusations. The executive,...", "source": "Bloomberg News", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/14/business/company-news-glaxo-says-it-will-fight-new-york-lawsuit.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SPITZER, ELIOT L"}, {"name": "persons", "value": "GARNIER, JEAN-PIERRE"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "organizations", "value": "PHARMACIA CORP"}, {"name": "organizations", "value": "GLAXOSMITHKLINE"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGSTORES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "DISCOUNT SELLING"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "2003-02-14T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "New York plans to sue two major pharmaceutical companies today, accusing them essentially of paying doctors and pharmacists to choose the companies' drugs over competing medicines. The state is joining six other states, including California and Texas, in a growing legal attack on a longstanding practice that the states say has cost state and federal governments and consumers hundreds of millions of dollars in recent years.", "headline": {"main": "New York Will Sue 2 Big Drug Makers On Doctor Discount"}, "abstract": "New York will sue pharmaceutical companies GlaxoSmithKline and Pharmacia, accusing them of paying doctors and pharmacists to choose companies' drugs over competing medicines; six other states, including California and Texas, have sued several drug companies; growing legal attack is on longstanding practice of giving discounts to doctors and pharmacies that buy their drugs; states say this costs state and federal governments and consumers hundreds of millions of dollars in recent years; lawsuits argue that drug companies, doctors and pharmacists all profit from their arrangement, at expense of taxpayer and patient, who has higher co-payment; Aventis is notified that it may also be sued; charts (M)", "print_page": "1", "word_count": 1423, "_id": "4fd270708eb7c8105d82c206", "snippet": "New York plans to sue two major pharmaceutical companies today, accusing them essentially of paying doctors and pharmacists to choose the companies' drugs over competing medicines.    The state is joining six other states, including California and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/13/business/new-york-will-sue-2-big-drug-makers-on-doctor-discount.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK STATE"}, {"name": "glocations", "value": "TEXAS"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "organizations", "value": "PHARMACIA CORP"}, {"name": "organizations", "value": "GLAXOSMITHKLINE"}, {"name": "organizations", "value": "AVENTIS"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "DRUGSTORES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "DISCOUNT SELLING"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Reed", "lastname": "ABELSON"}, {"organization": "", "role": "reported", "rank": 2}], "original": "By REED ABELSON and JONATHAN D. GLATER"}, "document_type": "article", "pub_date": "2003-02-13T00:00:00Z", "section_name": "Front Page; Health; Business"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "He's at it again. President Bush traveled to Nashville on Monday to talk, among other things, about compassion, which is a topic this president probably should leave alone. Mr. Bush's idea of compassion tends to send a shiver of dread through those who are disadvantaged.", "headline": {"main": "Heavy Lifting"}, "abstract": "Bob Herbert Op-Ed column says Pres Bush's domestic policies and budget cuts for social programs are sure to enlarge ranks of the poor and suffering, the very people he urges religious organizations to help", "print_page": "41", "word_count": 699, "_id": "4fd241c78eb7c8105d7da698", "snippet": "He's at it again.    President Bush traveled to Nashville on Monday to talk, among other things, about compassion, which is a topic this president probably should leave alone. Mr. Bush's idea of compassion tends to send a shiver of dread through...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/13/opinion/heavy-lifting.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "SOCIAL CONDITIONS AND TRENDS"}, {"name": "subject", "value": "UNITED STATES ECONOMY"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "RELIGION AND CHURCHES"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Bob", "lastname": "HERBERT"}], "original": "By BOB HERBERT"}, "document_type": "article", "pub_date": "2003-02-13T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Doctors in New York and Connecticut are planning to protest rising malpractice insurance costs next month in Albany and Hartford, voicing their anger over the same rancorous issue that led New Jersey doctors to stage a work slowdown. Last week, New Jersey joined a growing list of states where physicians have held limited walkouts to demand so-called tort reform, including a cap on the amount of compensation for pain and suffering that juries can award patients who win malpractice lawsuits.", "headline": {"main": "In Connecticut And New York, Doctors Plan To Join Protest"}, "abstract": "Doctors in New York and Connecticut will protest rising malpractice insurance costs next month in Albany and Hartford; say they are not threatening any job action but instead will rely on intense lobbying efforts (M)", "print_page": "5", "word_count": 546, "_id": "4fd22a778eb7c8105d7b56b5", "snippet": "Doctors in New York and Connecticut are planning to protest rising malpractice insurance costs next month in Albany and Hartford, voicing their anger over the same rancorous issue that led New Jersey doctors to stage a work slowdown.    Last week,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/13/nyregion/in-connecticut-and-new-york-doctors-plan-to-join-protest.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK STATE"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "glocations", "value": "CONNECTICUT"}, {"name": "subject", "value": "INSURANCE"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MALPRACTICE"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "SLOWDOWNS AND JOB ACTIONS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By DAVID M. HERSZENHORN"}, "document_type": "article", "pub_date": "2003-02-13T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign Desk", "lead_paragraph": "During a routine self-examination last May, Shirley Magee found a lump on her breast. Within weeks she had it and some lymph nodes removed. So far so good, until it came to the follow-up therapy. Mrs. Magee, a 55-year-old public school secretary, researched her condition on the Internet, and read that optimally, radiation treatment should begin two weeks after surgery. But the local provincial government clearinghouse that manages the waiting time for radiation therapy told her she had to wait until the end of September -- nearly three months after her surgery -- to begin treatment.", "headline": {"main": "Long Lines Mar Canada's Low-Cost Health Care"}, "abstract": "Public confidence in Canada's national health care system is being eroded by growing complaints about long lines for diagnosis and surgery, as well as widespread 'line-jumping' by affluent and connected; it has become leading issue for next year's national election; recent government study indicates that 4.3 million Canadian adults--18 percent of those who saw doctor in 2001--reported they had difficulty seeing doctor or getting test or surgery done in timely fashion; Canada spends $66 billion a year on health care, but budget cutbacks since early 1990's have impeded efforts to keep health care up to date; photo; graph (M)", "print_page": "3", "word_count": 1210, "_id": "4fd23afa8eb7c8105d7cfbc1", "snippet": "During a routine self-examination last May, Shirley Magee found a lump on her breast. Within weeks she had it and some lymph nodes removed. So far so good, until it came to the follow-up therapy.    Mrs. Magee, a 55-year-old public school secretary,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/13/world/long-lines-mar-canada-s-low-cost-health-care.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "CANADA"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Clifford", "lastname": "KRAUSS"}], "original": "By CLIFFORD KRAUSS"}, "document_type": "article", "pub_date": "2003-02-13T00:00:00Z", "section_name": "World; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The health insurer Aetna reported a profit today for the fourth quarter in contrast to a loss a year ago. Aetna also said that it expected earnings for the first quarter and the year to top Wall Street expectations. John W. Rowe, the chairman and chief executive, said the company's turnaround was accelerating, and moving faster than executives and some analysts had expected.", "headline": {"main": "Aetna Earnings Beat Estimates Of Analysts"}, "abstract": "Aetna reports profit for fourth quarter in contrast to loss year ago; earned $98.2 million compared to loss of $187.6 million year ago; revenue fell to $4.72 billion from $6.04 billion; net loss for 2002 was $2.52 billion compared with loss of $279.6 million in 2001; revenue fell to $19.88 billion in 2002 from $25.19 billion in 2001 (M)", "print_page": "5", "word_count": "373", "_id": "4fd22af68eb7c8105d7b613d", "snippet": "The health insurer Aetna reported a profit today for the fourth quarter in contrast to a loss a year ago. Aetna also said that it expected earnings for the first quarter and the year to top Wall Street expectations.     John W. Rowe, the chairman and...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/12/business/aetna-earnings-beat-estimates-of-analysts.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "AETNA INC"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "COMPANY REPORTS"}], "byline": null, "document_type": "article", "pub_date": "2003-02-12T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "In searching for a suitable camp for her 11-year-old daughter, Linda Friedman Schmidt of Franklin Lakes, N.J., interviewed at least a dozen camp directors. Among her questions was one that parents rarely ask: is milk served at every meal? The answer each time was ''only at breakfast.''", "headline": {"main": "Parents' Rite of Passage: Shopping for a Camp", "kicker": "PERSONAL HEALTH"}, "abstract": "Jane E Brody column offer guidelines for parents in choosing summer camp for a child; drawing (M)", "print_page": "6", "word_count": 1098, "_id": "4fd22a768eb7c8105d7b561b", "snippet": "In searching for a suitable camp for her 11-year-old daughter, Linda Friedman Schmidt of Franklin Lakes, N.J., interviewed at least a dozen camp directors.    Among her questions was one that parents rarely ask: is milk served at every meal? The...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/11/health/personal-health-parents-rite-of-passage-shopping-for-a-camp.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "PERSONAL HEALTH (TIMES COLUMN)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "CAMPS AND CAMPING"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2003-02-11T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "I've just had my genome scanned, and unfortunately I have common mutations that give me a mildly increased risk for dangerous blood clots, schizophrenia and type 2 diabetes. Worst of all, my ApoE gene indicates I have three times the average risk for getting Alzheimer's. On the other hand, I don't have plenty of common nasty mutations, such as those associated with colon cancer and melanoma. All in all, the analysis of 130 of my genetic markers, coupled with more traditional medical data, suggests that I'm subsidizing my life insurance company -- which is the way I like it.", "headline": {"main": "Staying Alive, Staying Human"}, "abstract": "Nicholas D Kristof Op-Ed column on enormous potential of genetic screening for mutations associated with various diseases the host of conundrums it raises", "print_page": "29", "word_count": 755, "_id": "4fd23afa8eb7c8105d7cfb05", "snippet": "I've just had my genome scanned, and unfortunately I have common mutations that give me a mildly increased risk for dangerous blood clots, schizophrenia and type 2 diabetes. Worst of all, my ApoE gene indicates I have three times the average risk for...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/11/opinion/staying-alive-staying-human.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "DNA (DEOXYRIBONUCLEIC ACID)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By NICHOLAS D. KRISTOF"}, "document_type": "article", "pub_date": "2003-02-11T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: Given the tremendous amount of money that the federal government spends every year in supporting vital biomedical research that often results in the discovery and creation of new cancer drugs, the government should have some say in how much ordinary citizens are to be charged (''Overpriced Cancer Drugs,'' editorial, Feb. 6).", "headline": {"main": "'Surcharge' by Doctors"}, "abstract": "Michael Pravica letter says doctors' practice of overbilling patients and insurance companies for cancer drugs is devious and harms relationship between doctor and patient (Feb 6, editorial)", "print_page": "28", "word_count": 116, "_id": "4fd22afa8eb7c8105d7b6432", "snippet": "To the Editor:    Given the tremendous amount of money that the federal government spends every year in supporting vital biomedical research that often results in the discovery and creation of new cancer drugs, the government should have some say in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/02/11/opinion/l-surcharge-by-doctors-275905.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PRAVICA, MICHAEL"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "DOCTORS"}], "byline": null, "document_type": "article", "pub_date": "2003-02-11T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 23, "offset": 0, "time": 59}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}